menu
    • menu

    Company profile for Nucleome Therapeutics

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat disease. The dark genome holds more than 90% of disease-linked genetic variants whose value remains untapped, representing a significant opportunity for drug discovery and development. The Company has the unique ability to link these variants to gene function and precisely map disease pathways. Nucleome’s cell type-specific p...
    Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat disease. The dark genome holds more than 90% of disease-linked genetic variants whose value remains untapped, representing a significant opportunity for drug discovery and development. The Company has the unique ability to link these variants to gene function and precisely map disease pathways. Nucleome’s cell type-specific platform creates high resolution 3D genome structure maps and enables variant functional validation at scale in primary cell types, enabling the discovery and development of novel, better and safer drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nucleome Therapeuticsunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Suite C, Second Floor, Schrodinger Building, Oxford Science Park, Oxford, OX4 ...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nucleome.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nucleome-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nucleome Appoints Experienced Biotech Executive Dr. Michelle
    Nucleome Appoints Experienced Biotech Executive Dr. Michelle

    16 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nucleome-therapeutics-appoints-experienced-biotech-executive-dr-michelle-morrow-as-chief-scientific-officer-302687862.html

    PR NEWSWIRE
    16 Feb 2026
    Share Share
    Nucleome Therapeutics Nominates First Preclinical Candidate
    Nucleome Therapeutics Nominates First Preclinical Candidate

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nucleome-therapeutics-nominates-first-preclinical-development-candidate-302654161.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Nucleome Therapeutics Founder, Oxford University Professor
    Nucleome Therapeutics Founder, Oxford University Professor

    06 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-06/nucleome-therapeutics-founder-professor-james-davies-and-oxford-university-publish-paper-in-prestigious-journal-cell

    PHARMIWEB
    06 Nov 2025
    Share Share
    Nucleome Appoints Dr John Davis, Forms Scientific Advisory Board
    Nucleome Appoints Dr John Davis, Forms Scientific Advisory Board

    25 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/25/2869494/0/en/Nucleome-Therapeutics-appoints-Dr-John-Davis-as-Non-Executive-Director-of-the-Board-and-establishes-Scientific-Advisory-Board-of-world-leading-experts.html

    GLOBENEWSWIRE
    25 Apr 2024
    Share Share
    Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer
    Nucleome Therapeutics appoints Dr Stephen Harrison as Chief Scientific Officer

    13 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/13/2778719/0/en/Nucleome-Therapeutics-appoints-Dr-Stephen-Harrison-as-Chief-Scientific-Officer.html

    GLOBENEWSWIRE
    13 Nov 2023
    Share Share
    Enara Bio, ROME & Nucleome Therapeutics to Host 2nd Annual Dark Genome Symposium
    Enara Bio, ROME & Nucleome Therapeutics to Host 2nd Annual Dark Genome Symposium

    01 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/01/2771059/0/en/Enara-Bio-ROME-Therapeutics-and-Nucleome-Therapeutics-to-Host-2nd-Annual-Dark-Genome-Symposium.html

    GLOBENEWSWIRE
    01 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search